Ketogenic diets are well established as a successful anticonvulsant therapy. Based on overlap between mechanisms postulated to underlie pain and inflammation, and mechanisms postulated to underlie therapeutic effects of ketogenic diets, recent studies have explored the ability for ketogenic diets to reduce pain. Here we review clinical and basic research thus far exploring the impact of a ketogenic diet on thermal pain, inflammation, and neuropathic pain.
ElliottAMSmithBHPennyKI. The epidemiology of chronic pain in the community. Lancet. 1999;354:1248–1252.
2.
BeckerNBondegaard-ThomsenAOlsenAK. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997;73:393–400.
3.
GurejeOVon KorffMSimonGEGaterR. Persistent pain and well-being: a World Health Organization study in primary care. J Am Med Assoc. 1998;280:147–151.
4.
WilderRM. The effects of ketonemia on the course of epilepsy. Mayo Clin Bull. 1921;2:307.
5.
WilderRM. High fat diets in epilepsy. Mayo Clin Bull. 1921;2:308.
6.
WoolfCJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306:686–688.
7.
RajaSNMeyerRACampbellJN. Peripheral mechanisms of somatic pain. Anesthesiology. 1988;68:571–590.
8.
StafstromCEOckulyJCMurphreeL. Anticonvulsant and antiepileptic actions of 2-deoxy-d-glucose in epilepsy models. Ann Neurol. 2009;65:435–447.
9.
FisherMCBodnarRJ.2-Deoxy-d-glucose antinociception and serotonin receptor subtype antagonists: test-specific effects in rats. Pharmacol Biochem Behav. 1992;43:1241–1246.
10.
de los Santos-ArteagaMSierra-DomínguezSAFontanellaGH. Analgesia induced by dietary restriction is mediated by the κ-opioid system. J Neurosci. 2003;23:11120–11126.
11.
YarbroughGGMcGuffin-ClineschmidtJC.In vivo behavioral assessment of central nervous system purinergic receptors. Eur J Pharmacol. 1981;76:137–144.
12.
SchmidtAPBöhmerAEAntunesC. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol. 2009;156:163–172.
13.
GoldmanNChenMFujitaT. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci. 2010;13:883–888.
14.
TakanoTChenXLuoF. Traditional acupuncture triggers a local increase in adenosine in human subjects. J Pain. 2012;13:1215–1223.
15.
ZhaoYTTekkökSKrnjevićK.2-Deoxy-d-glucose-induced changes in membrane potential, input resistance, and excitatory postsynaptic potentials of CA1 hippocampal neurons. Can J Physiol Pharmacol. 1997;75:368–374.
16.
MinorTRRoweMKSoames-JobRFFergusonEC. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav Brain Res. 2001;120:203–212.
17.
KawamuraMJrRuskinDNMasinoSA. Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors and KATP channels. J Neurosci. 2010;30:3886–3895.
18.
JinkaTRCarlsonZAMooreJTDrewKL. Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats. Psychopharmacology. 2010;209:217–224.
19.
MasinoSALiTTheofilasP. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest. 2011;121:2679–2683.
20.
MartinsDFMazzardo-MartinsLSoldiF. High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system. Neuroscience. 2013;234:69–76.
21.
RuskinDNMasinoSA. The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy. Front Neurosci. 2012;6:33.
22.
RuskinDNKawamuraMJrMasinoSA. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One. 2009;4:e8349.
23.
RuskinDNSuterTACSRossJLMasinoSA.Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats. J Pain. 2013;pii: S1526–5900(13)00023–0.
24.
RuskinDNRossJLKawamuraMJr. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1 J mouse model of Huntington’s disease. Physiol Behav. 2011;103:501–507.
25.
ZieglerDRGamaroGDAraújoE. Nociception and locomotor activity are increased in ketogenic diet fed rats. Physiol Behav. 2005;84:421–427.
26.
LikhodiiSSMusaKMendoncaA. Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia. 2000;41:1400–1410.
27.
VeechRL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004;70:309–319.
28.
KimDYDavisLMSullivanPG. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem. 2007;101:1316–1326.
MaaloufMRhoJM. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J Neurosci Res. 2008;86:3322–3330.
32.
MaaloufMSullivanPGDavisL. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145:256–264.
33.
HacesMLHernandez-FonsecaKMedina-CamposON. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol. 2008;211:85–96.
34.
SullivanPGRippyNADorenbosK. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004;55:576–580.
35.
KimDYHaoJLiuR. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One. 2012;7:e35476.
36.
TendlerDLinSYancyWSJr. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2007;52:589–593.
37.
Pérez-GuisadoJMuñoz-SerranoA. The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study. J Med Food. 2011;14:677–680.
MichalikLAuwerxJBergerJP. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006;58:726–741.
40.
CuzzocreaSPisanoBDugoL. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol. 2004;483:79–93.
41.
CuzzocreaSMazzonEDugoL. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 2003;48:3544–3556.
42.
LoVermeJFuJAstaritaG. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005;67:15–19.
43.
CuzzocreaSMazzonEDi PaoloR. The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation. J Leukoc Biol. 2006;79:999–1010.
44.
BlanquartCBarbierOFruchartJC. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol. 2003;85:267–273.
LindenJ. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Ann Rev Pharmacol Toxicol. 2001;41:775–787.
47.
NgamsriK-CWagnerRVollmerI. Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol. 2010;185:4374–4384.
48.
WangJHuxleyVH. Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability. Am J Physiol Heart Circ Physiol. 2006;291:H3094–H3105.
49.
SorkinLSMooreJBoyleDL. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol. 2003;184:162–168.
50.
CampbellJNMeyerRA. Mechanisms of neuropathic pain. Neuron. 2006;52:77–92.
51.
PortenoyRKFoleyKMInturrisiCE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990;43:273–286.
52.
DickensonAHSuzukiR. Opioids in neuropathic pain: clues from animal studies. Eur J Pain. 2005;9:113–116.
53.
BennettGJXieYK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107.
54.
UhlemannERNeimsAH. Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Exp Ther. 1972;180:231–238.
55.
SamalaRWillisSBorgesK. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 2008;81:119–127.
56.
HartmanALZhengXBergbowerE. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia. 2010;51:1395–1402.
57.
SeokJWarrenHSCuencaAG. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad Sci U S A. 2013;110:3507–3512.
58.
RhoJMZupec-KaniaBMasinoSA. Ketogenic diet and epilepsy: the role of adenosine. In: MasinoSABoisonD, eds. Adenosine: A Key Link Between Metabolism and Brain Activity. New York: Springer; 2013.
MorrisonPFPyzikPLHamdyR. The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia. 2009;50:1999–2001.
61.
PoplawskiMMMastaitisJWIsodaF. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One. 2011;6:e18604.
62.
AtladottirHOThorsenPSchendelDE. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch Pediatr Adolesc Med. 2010;164:470–477.
